Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.

Ifere GO, Equan A, Gordon K, Nagappan P, Igietseme JU, Ananaba GA.

Cancer Epidemiol. 2010 Aug;34(4):461-71. doi: 10.1016/j.canep.2010.04.009. Epub 2010 May 12.

2.

Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.

Ifere GO, Barr E, Equan A, Gordon K, Singh UP, Chaudhary J, Igietseme JU, Ananaba GA.

Cancer Detect Prev. 2009;32(4):319-28. doi: 10.1016/j.cdp.2008.12.002. Epub 2009 Jan 30.

PMID:
19186008
3.

The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.

Kovacevic Z, Sivagurunathan S, Mangs H, Chikhani S, Zhang D, Richardson DR.

Carcinogenesis. 2011 May;32(5):732-40. doi: 10.1093/carcin/bgr046. Epub 2011 Mar 11.

4.

L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.

Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH.

Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C676-85. doi: 10.1152/ajpcell.00180.2011. Epub 2011 Nov 23.

5.

Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.

Tsui KH, Chang YL, Feng TH, Chang PL, Juang HH.

Prostate. 2012 Sep 15;72(13):1431-42. doi: 10.1002/pros.22494. Epub 2012 Jan 30.

PMID:
22290289
6.

Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.

Dixon KM, Lui GY, Kovacevic Z, Zhang D, Yao M, Chen Z, Dong Q, Assinder SJ, Richardson DR.

Br J Cancer. 2013 Feb 5;108(2):409-19. doi: 10.1038/bjc.2012.582. Epub 2013 Jan 3.

7.

γ-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines.

Hirsch GE, Parisi MM, Martins LA, Andrade CM, Barbé-Tuana FM, Guma FT.

Prostate. 2015 Jun;75(8):783-97. doi: 10.1002/pros.22960. Epub 2015 Jan 25.

PMID:
25619388
8.

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.

Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.

Int J Cancer. 2012 Jun 15;130(12):2812-23. doi: 10.1002/ijc.26284. Epub 2011 Aug 30.

9.

Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).

Liu R, Li J, Teng Z, Zhang Z, Xu Y.

PLoS One. 2013 Jul 16;8(7):e68982. doi: 10.1371/journal.pone.0068982. Print 2013.

10.

p53-dependent NDRG1 expression induces inhibition of intestinal epithelial cell proliferation but not apoptosis after polyamine depletion.

Zhang AH, Rao JN, Zou T, Liu L, Marasa BS, Xiao L, Chen J, Turner DJ, Wang JY.

Am J Physiol Cell Physiol. 2007 Jul;293(1):C379-89. Epub 2007 Apr 18.

11.

N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.

Angst E, Dawson DW, Stroka D, Gloor B, Park J, Candinas D, Reber HA, Hines OJ, Eibl G.

Surgery. 2011 May;149(5):614-24. doi: 10.1016/j.surg.2010.11.002. Epub 2011 Jan 14.

PMID:
21236457
12.

N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.

Akiba J, Murakami Y, Noda M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H.

Cancer Lett. 2011 Nov 1;310(1):25-34. doi: 10.1016/j.canlet.2011.05.034. Epub 2011 Jun 24.

PMID:
21775055
13.

N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.

Pflueger D, Rickman DS, Sboner A, Perner S, LaFargue CJ, Svensson MA, Moss BJ, Kitabayashi N, Pan Y, de la Taille A, Kuefer R, Tewari AK, Demichelis F, Chee MS, Gerstein MB, Rubin MA.

Neoplasia. 2009 Aug;11(8):804-11.

15.

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J.

BMC Cancer. 2009 Jun 7;9:173. doi: 10.1186/1471-2407-9-173.

16.

The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells.

Palozza P, Sestito R, Picci N, Lanza P, Monego G, Ranelletti FO.

Carcinogenesis. 2008 Nov;29(11):2153-61. doi: 10.1093/carcin/bgn018. Epub 2008 Jul 16.

17.

Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.

Juang HH, Chung LC, Sung HC, Feng TH, Lee YH, Chang PL, Tsui KH.

Prostate. 2013 Oct;73(14):1495-506. doi: 10.1002/pros.22697. Epub 2013 Jun 21.

PMID:
23794209
18.
19.

Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets.

Narayanan BA, Narayanan NK, Re GG, Nixon DW.

Int J Cancer. 2003 Mar 20;104(2):204-12.

20.

Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.

Yamasaki M, Nomura T, Sato F, Mimata H.

Oncol Rep. 2007 Nov;18(5):1145-53.

PMID:
17914565
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk